Mechanisms of probiotic actions - A review

International Journal of Medical Microbiology

Volumn 300, Issue 1, 2010, Pages 57-62

  Oelschlaeger, Tobias A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Mechanisms of action; Probiotics

Indexed keywords

BACTERIAL DNA; BACTERIAL TOXIN; BACTERIOCIN; BETA DEFENSIN 2; BILE ACID; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MYCOTOXIN; PEPTIDOGLYCAN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL CELL WALL; BACTERIUM ADHERENCE; BILE ACID METABOLISM; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; FOOD; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS CASEI; NATURAL KILLER CELL; NONHUMAN; PANETH CELL; REGULATORY T LYMPHOCYTE; SHORT SURVEY;

ANTI-INFECTIVE AGENTS; ANTIMETABOLITES; BACTERIA; HUMANS; IMMUNOLOGIC FACTORS; PROBIOTICS;

EID: 71649090661     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2009.08.005     Document Type: Short Survey

References (54)

1. Altenhoefer A., Oswald S., Sonnenborn U., Enders C., Schulze J., Hacker J., and Oelschlaeger T.A. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 40 (2004) 223-229
2. Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., and Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72 (2004) 2240-2247
3. Botes M., Loos B., van Reenen C.A., and Dicks L.M.T. Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments. Arch. Microbiol. 190 (2008) 573-584
4. Braat H., van den Brande J., van Tol E., Hommes D., Peppelenbosch M., and van Deventer S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dentritic cell function. Am. J. Clin. Nutr. 80 (2004) 1618-1625
5. Carey C.M., Kostrzynska M., Ojha S., and Thompson S. The effect of probiotics and organic acids on shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J. Microbiol. Methods 73 (2008) 125-132
6. Castagliuolo I., LaMont T., Nikulasson S.T., and Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect. Immun. 64 (1996) 5225-5232
7. Chandra I., Kosters A., Sethi G., Kunnunmakkara A.B., Aggarwal B.B., and Versalovic J. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-κB and MAPK signalling. Cell. Microbiol. 10 (2008) 1442-1452
8. Cheikhyoussef A., Pogor N., Chen W., and Zhang H. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int. J. Food Microbiol. 125 (2008) 215-222
9. Chen X., Kokkotou E.G., Mustafa N., Ramakrishnan Bhaskar K., Sougioultzis S., O'Brien M., Pothoulakis C., and Kelly C.P. Sacchamromyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J. Biol. Chem. 281 (2006) 24449-24454
10. Cleusix V., Lacroix C., Vollenweider S., and Le Blay G. Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces. FEMS Microbiol. Ecol. 63 (2008) 56-64
11. Collado M.C., Grzeskowiak L., and Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr. Microbiol. 55 (2007) 260-265
12. Collado M.C., Meriluoto J., and Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 45 (2007) 454-460
13. Corr S.C., Li Y., Riedel C.U., O'Toole P.W., Hill C., and Gahan C.G.M. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 104 (2007) 7617-7621
14. Elli M., Zink R., Rytz A., Reniero R., and Morelli L. Iron requirement of Lactobacillus spp. in completely chemically defined growth media. J. Appl. Microbiol. 88 (2000) 695-703
15. Geier M.S., Butler R.N., and Howarth G.S. Probiotics, prebiotics and synbiotics. A role in chemoprevention of colorectal cancer?. Cancer Biol. Ther. 5 (2006) 1265-1269
16. Golowczyc M.A., Mobili P., Garrote G.L., Abraham A.G., and De Antoni G.L. Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis. Int. J. Food Microbiol. 118 (2007) 264-273
17. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., and Mercenier A. Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. USA 102 (2005) 10321-10326
18. Gratz S., Täubel M., Juvonen R.O., Viluksela M., Turner P.C., Mykkänen H., and El-Nezami H. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B1 in rats. Appl. Environ. Microbiol. 72 (2006) 7398-7400
19. Gratz S., Wu Q.K., El-Nezami H., Juvonen R.O., Mykkänen H., and Turner P.C. Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 cells. Appl. Environ. Microbiol. 73 (2007) 3958-3964
20. Große C., Scherer J., Koch D., Otto M., Taudte N., and Grass G. A new ferrous iron-uptake transporter, EfeuU (YcdN), from Escherichia coli. Mol. Microbiol. 62 (2006) 120-131
21. Grozdanov L., Raasch C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., and Dobrindt U. Analysis of the genome structure of the non-pathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 186 (2004) 5432-5441
22. Hess P., Altenhöfer A., Khan A.S., Daryab N., Kim K.S., Hacker J., and Oelschlaeger T.A. A Salmonella fim homologue in Citrobacter freundii mediates invasion in vitro and crossing of the blood brain barrier in the rat pup model. Infect. Immun. 72 (2004) 5298-5307
23. Hirayama K., and Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2 (2000) 681-686
24. Ingrassia I., Leplingard A., and Darfeuille-Michaud A. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl. Environ. Microbiol. 71 (2005) 2880-2887
25. Kamada N., Maeda K., Inoue N., Hisamatsu T., Okamoto S., Hong K.S., Yamada T., Watanabe N., Tsuchimoto K., Ogata H., and Hibi T. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect. Immun. 76 (2008) 214-220
26. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., and Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat. Immunol. 5 (2004) 104-112
27. Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., and Schulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53 (2004) 1617-1623
28. Lee J.W., Shin J.G., Kim E.H., Kang H.E., Yim I.B., Kim J.Y., Joo H.G., and Woo H.J. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci. 5 (2004) 41-48
29. Mack D.R., Ahrne S., Hyde L., Wei S., and Hollingsworth M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52 (2003) 827-833
30. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
31. Maqueda M., Sanchez-Hidalgo M., Fernandez M., Montalban-Lopez M., Valdivia E., and Martinez-Bueno M. Genetic features of circular bacteriocins produced by Gram-positive bacteria. FEMS Microbiol. Rev. 32 (2008) 2-22
32. Matsuo K., Ota H., Akamatsu T., Sugiyama A., and Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 40 (1997) 782-789
33. Nybom S.M.K., Salminen S.J., and Meriluoto J.A.O. Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution. Toxicon 52 (2008) 214-220
34. O'Mahony L., Feeney M., O'Nalloran S., Murphy L., Kiely B., Fitzgibbon J., Lee G., O'Sullivan G., Shanahan F., and Collins J.K. Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15 (2001) 1219-1225
35. Paton A.W., Morona R., and Paton J.C. Designer probiotics for prevention of enteric infections. Nat. Rev. Microbiol. 4 (2006) 193-200
36. Petrof E.O., Kojima K., Ropeleski M.J., Musch M.W., Tao Y., De Simon C., and Chang E.B. Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127 (2004) 1474-1487
37. Qamar A., Aboudola S., Warny M., Michetti P., Pothoulakis C., LaMont J.T., and Kelly C.P. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 69 (2001) 2762-2765
38. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., and Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126 (2004) 520-528
39. Roos S., and Jonsson H. A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 148 (2002) 433-442
40. Sanchez B., Bressollier P., and Urdaci M.C. Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host. FEMS Immunol. Med. Mirobiol. 54 (2008) 1-17
41. Schlee M., Wehkamp J., Altenhoefer A., Oelschlaeger T.A., Stange E.F., and Fellermann K. Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75 (2007) 2399-2407
42. Sheil B., McCarthy J., O'Mahony L., Bennet M.W., Ryan P., Fitzgibbon J.J., Kiely B., Collins J.K., and Shanahan F. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53 (2004) 694-700
43. Sun J., Shi Y.H., Le G.W., and Ma X.Y. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J. Gastroenterol. 11 (2005) 6330-6337
44. Takahashi M., Taguchi H., Yamaguchi H., Osaki T., Komatsu A., and Kamiya S. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 41 (2004) 219-226
45. Takeda K., Suzuki T., Shimada S.-I., Shida K., Nanno M., and Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 146 (2006) 109-115
46. Tooley K., Howarth G., Lymn K., Lawrence A., and Butler R. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol. Ther. 5 (2006) 593-600
47. Turner P.C., Wu Q.K., Piekkola S., Gratz S., Mykkänen H., and El-Nezami H. Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol. Food Chem. Toxicol. 46 (2008) 2118-2123
48. Ukena S.N., Singh A., Dringenberg U., Engelhardt R., Seidler U., Hansen W., Bleich A., Bruder D., Franzke A., Rogler G., Suerbaum S., Buer J., Gunzer F., and Westendorf A.M. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2 (2007) e1308
49. Van Guelpen B., Hultdin J., Johansson I., Hallmans G., Stenling R., Riboli E., Winkvist A., and Palmqvist R. Low folate levels may protect against colorectal cancer. Gut 55 (2006) 1461-1466
50. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schäffeler E., Schlee M., Herrlinger K.R., Stallmach A., Noack F., Fritz P., Schröder J.M., Belvins C.L., Fellermann K., and Stange E.F. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53 (2004) 1658-1664
51. Weinberg E.D. The Lactobacillus anomaly: total iron abstinence. Perspect. Biol. Med. 40 (1997) 578-583
52. Wohlgemuth S., Loh G., and Blaut M. Recent developments and perspectives in the investigation of probiotic effects. Int. J. Med. Microbiol. 300 (2010) 10.1016/j.ijmm.2009.08.003
53. Yan F., Cao H., Cover T.L., Whitehead R., Washington M.K., and Polk D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132 (2007) 562-575
54. Zyrek A.A., Cichon C., Helms S., Enders C., Sonnenborn U., and Schmidt M.A. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKC redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 9 (2007) 804-816